Compass Therapeutics : 2024 Proxy Supplemental : comparemela

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


SCHEDULE 14A


Proxy...

Related Keywords

United States , Washington , Delaware , Massachusetts , Boston , Neil Lerner , Vered Bisker Leib , Thomas Schuetz , Ellen Chiniara , Carl Gordon , Company Board Of Directors The , Board Of Directors The Company , Securities Exchange , Compass Therapeutics Inc , Commission File Number , Exchange Act , Company The Separation Agreement , Company On , Nasdaq , Consulting Services , Statement Pursuant , Commission Only , Material Pursuant , Specified In Its Charter , Filing Proxy Statement , Filing Fee , Exchange Act Rules , Securities Exchange Act , Principal Executive Offices , Zip Code , Securities Act , Certain Officers , Compensatory Arrangements , Chief Executive Officer , Principal Executive Officer , Principal Financial , Accounting Officer , Compass Therapeutics , Separation Agreement , Consulting Agreement , Consulting Period , Consulting End Date , Consulting End , Vice Chair , Principal Accounting Officer , Current Report , Proxy Statement , Chief Executive , Page Interactive Data File , Benefits Upon Termination , Good Reason Outside , Employment Agreement , Employment Separation Date , Senior Consultant , Equity Documents , Separation Date , Base Salary , Such Severance Amount , Consolidated Omnibus Budget Reconciliation Act , Severance Amount , Option Exercise Period , Exercise Period Extension , Severance Benefits , Exercise Period , Age Discrimination , Employment Act , Massachusetts Wage Act , Accrued Obligations , Press Release , Employment Separation , Agreement Related Information ,